NCCN Task Force Report: Management of Neuropathy in Cancer
Michael D. Stubblefield, Jamie H. Von Roenn(American Society of Clinical Oncology), Gerwyn Morris(Barwon Health), Maria Ho, Sudhakar Tummala(The University of Texas MD Anderson Cancer Center), Larry Junck(University of Michigan), Christian M. Custodio(Memorial Sloan Kettering Cancer Center), Harold J. Burstein(Dana-Farber Cancer Institute), Gary Deng, Allen W. Burton(Abbott (United States)), Judith A. Paice(Northwestern University)
Cited by 259
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k